21 datasets found
  1. T

    Acasti Pharma | ACST - Stock Price | Live Quote | Historical Chart

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 4, 2015
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2015). Acasti Pharma | ACST - Stock Price | Live Quote | Historical Chart [Dataset]. https://tradingeconomics.com/acst:us
    Explore at:
    json, xml, excel, csvAvailable download formats
    Dataset updated
    Dec 4, 2015
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

  2. T

    Acasti Pharma | ACST - Market Capitalization

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 10, 2018
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2018). Acasti Pharma | ACST - Market Capitalization [Dataset]. https://tradingeconomics.com/acst:us:market-capitalization
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    Jun 10, 2018
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $30.3M in Market Capitalization this October of 2025, considering the latest stock price and the number of outstanding shares.Data for Acasti Pharma | ACST - Market Capitalization including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  3. T

    Acasti Pharma | ACST - Outstanding Shares

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jan 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Outstanding Shares [Dataset]. https://tradingeconomics.com/acst:us:outstanding-shares
    Explore at:
    json, csv, xml, excelAvailable download formats
    Dataset updated
    Jan 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $10.14M in Outstanding Shares in January of 2025. Data for Acasti Pharma | ACST - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  4. T

    Acasti Pharma | ACST - Loan Capital

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Acasti Pharma | ACST - Loan Capital [Dataset]. https://tradingeconomics.com/acst:us:loan-capital
    Explore at:
    xml, excel, json, csvAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $0 in Loan Capital for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Loan Capital including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  5. T

    Acasti Pharma | ACST - Sales Revenues

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Acasti Pharma | ACST - Sales Revenues [Dataset]. https://tradingeconomics.com/acst:us:sales
    Explore at:
    excel, csv, xml, jsonAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $-4.76M in Sales Revenues for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  6. T

    Acasti Pharma | ACST - Current Assets

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Current Assets [Dataset]. https://tradingeconomics.com/acst:us:current-assets
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $20.52M in Current Assets for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Current Assets including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  7. T

    Acasti Pharma | ACST - Assets

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Assets [Dataset]. https://tradingeconomics.com/acst:us:assets
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $69.8M in Assets for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Assets including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  8. T

    Acasti Pharma | ACST - Cash And Equivalent

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Cash And Equivalent [Dataset]. https://tradingeconomics.com/acst:us:cash-and-equivalent
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $20M in Cash and Equivalent for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Cash And Equivalent including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  9. AMD Faces Stock Decline Amid Data Center Challenges - News and Statistics -...

    • indexbox.io
    doc, docx, pdf, xls +1
    Updated Aug 1, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    IndexBox Inc. (2025). AMD Faces Stock Decline Amid Data Center Challenges - News and Statistics - IndexBox [Dataset]. https://www.indexbox.io/blog/amds-data-center-struggles-impact-stock-performance/
    Explore at:
    doc, pdf, xlsx, docx, xlsAvailable download formats
    Dataset updated
    Aug 1, 2025
    Dataset provided by
    IndexBox
    Authors
    IndexBox Inc.
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2012 - Aug 1, 2025
    Area covered
    United States
    Variables measured
    Market Size, Market Share, Tariff Rates, Average Price, Export Volume, Import Volume, Demand Elasticity, Market Growth Rate, Market Segmentation, Volume of Production, and 4 more
    Description

    AMD's data center business struggles cast a shadow on its stock performance, highlighting challenges in AI computing and competition with Nvidia.

  10. T

    Acasti Pharma | ACST - Interest Expense On Debt

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Acasti Pharma | ACST - Interest Expense On Debt [Dataset]. https://tradingeconomics.com/acst:us:interest-expense-on-debt
    Explore at:
    csv, json, xml, excelAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $0 in Interest Expense on Debt for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Interest Expense On Debt including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  11. T

    Acasti Pharma | ACST - Trade Creditors

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Trade Creditors [Dataset]. https://tradingeconomics.com/acst:us:trade-creditors
    Explore at:
    xml, json, csv, excelAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $1.34M in Trade Creditors for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  12. T

    Acasti Pharma | ACST - Net Income

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Net Income [Dataset]. https://tradingeconomics.com/acst:us:net-income
    Explore at:
    csv, json, excel, xmlAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $-3.36M in Net Income for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Net Income including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  13. T

    Acasti Pharma | ACST - Employees Total Number

    • tradingeconomics.com
    csv, excel, json, xml
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS, Acasti Pharma | ACST - Employees Total Number [Dataset]. https://tradingeconomics.com/acst:us:employees
    Explore at:
    csv, xml, json, excelAvailable download formats
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 15, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $32 in Employees for its fiscal year ending in March of 2021. Data for Acasti Pharma | ACST - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  14. T

    Acasti Pharma | ACST - Interest Income

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Acasti Pharma | ACST - Interest Income [Dataset]. https://tradingeconomics.com/acst:us:interest-income
    Explore at:
    xml, json, excel, csvAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $-0.36 in Interest Income for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Interest Income including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  15. T

    Acasti Pharma | ACST - Current Liabilities

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Current Liabilities [Dataset]. https://tradingeconomics.com/acst:us:current-liabilities
    Explore at:
    xml, json, csv, excelAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 13, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $2.32M in Current Liabilities for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  16. T

    Acasti Pharma | ACST - Ordinary Share Capital

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Dec 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2024). Acasti Pharma | ACST - Ordinary Share Capital [Dataset]. https://tradingeconomics.com/acst:us:ordinary-share-capital
    Explore at:
    excel, json, csv, xmlAvailable download formats
    Dataset updated
    Dec 15, 2024
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $1000 in Ordinary Share Capital for its fiscal quarter ending in December of 2024. Data for Acasti Pharma | ACST - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  17. T

    Acasti Pharma | ACST - Trade Debtors

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Trade Debtors [Dataset]. https://tradingeconomics.com/acst:us:trade-debtors
    Explore at:
    json, excel, xml, csvAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $20K in Trade Debtors for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Trade Debtors including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  18. T

    Acasti Pharma | ACST - Selling And Administration Expenses

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Selling And Administration Expenses [Dataset]. https://tradingeconomics.com/acst:us:selling-and-administration-expenses
    Explore at:
    csv, xml, excel, jsonAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $2.14M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Selling And Administration Expenses including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  19. T

    Acasti Pharma | ACST - Equity Capital And Reserves

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Jun 15, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2025). Acasti Pharma | ACST - Equity Capital And Reserves [Dataset]. https://tradingeconomics.com/acst:us:equity-capital-and-reserves
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    Jun 15, 2025
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $63.55M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025. Data for Acasti Pharma | ACST - Equity Capital And Reserves including historical, tables and charts were last updated by Trading Economics this last October in 2025.

  20. T

    Acasti Pharma | ACST - PE Price to Earnings

    • tradingeconomics.com
    csv, excel, json, xml
    Updated Mar 15, 2021
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    TRADING ECONOMICS (2021). Acasti Pharma | ACST - PE Price to Earnings [Dataset]. https://tradingeconomics.com/acst:us:pe
    Explore at:
    excel, xml, csv, jsonAvailable download formats
    Dataset updated
    Mar 15, 2021
    Dataset authored and provided by
    TRADING ECONOMICS
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Jan 1, 2000 - Oct 14, 2025
    Area covered
    United States
    Description

    Acasti Pharma reported $9.94 in PE Price to Earnings for its fiscal quarter ending in March of 2021. Data for Acasti Pharma | ACST - PE Price to Earnings including historical, tables and charts were last updated by Trading Economics this last October in 2025.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
TRADING ECONOMICS (2015). Acasti Pharma | ACST - Stock Price | Live Quote | Historical Chart [Dataset]. https://tradingeconomics.com/acst:us

Acasti Pharma | ACST - Stock Price | Live Quote | Historical Chart

Explore at:
json, xml, excel, csvAvailable download formats
Dataset updated
Dec 4, 2015
Dataset authored and provided by
TRADING ECONOMICS
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Time period covered
Jan 1, 2000 - Oct 14, 2025
Area covered
United States
Description

Acasti Pharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.

Search
Clear search
Close search
Google apps
Main menu